Reviewing the EADV Data: Deuruxolitinib in Alopecia Areata

October 1, 2024

Sun Pharma’s JAK Inhibitor Dims Anxiety and Depression Symptoms in AA

September 25, 2024

Decoded: New Gene for “Spindle Hair”

September 4, 2024

Study: Obese Kids May Be More Likely to Develop AD, PsO, or AA

August 21, 2024

JAK Inhibition May Improve Multiple Autoimmune Conditions in People with Down Syndrome

August 13, 2024

What Will the FDA Approval of Sun Pharma’s Alopecia Drug Mean for Patients?

July 29, 2024

It’s a “Three-Peat”: FDA Approves LEQSELVI (Deuruxolitinib) for the Treatment of Severe AA

July 26, 2024

Mount Sinai Secures Large NIH Grant to Study JAK Inhibition in People with Down Syndrome and AA or AD

July 11, 2024

ICYMI: Revolutionizing Alopecia Areata Recap With Brett King, MD, PhD

June 21, 2024

Permanent Makeup in Dermatology: New Report Reviews Techniques, Regulations, and Risks

June 18, 2024

AA Pipeline Update: Equillium’s EQ101 Shows Promise in Phase 2 Trial

June 5, 2024

Soterios Pharma’s STS-01 Meets Efficacy Endpoints in AA Trial

May 31, 2024